BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1378802)

  • 1. Altered content and distribution of tenascin in colitis, colon adenoma, and colorectal carcinoma.
    Riedl SE; Faissner A; Schlag P; Von Herbay A; Koretz K; Möller P
    Gastroenterology; 1992 Aug; 103(2):400-6. PubMed ID: 1378802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular matrix proteins in colorectal carcinomas. Expression of tenascin and fibronectin isoforms.
    Hauptmann S; Zardi L; Siri A; Carnemolla B; Borsi L; Castellucci M; Klosterhalfen B; Hartung P; Weis J; Stöcker G
    Lab Invest; 1995 Aug; 73(2):172-82. PubMed ID: 7543628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction and altered distribution of tenascin in the basal lamina of colorectal adenomas and carcinomas.
    Riedl S; Möller P; Faissner A; Schlag P
    EXS; 1992; 61():277-81. PubMed ID: 1377543
    [No Abstract]   [Full Text] [Related]  

  • 4. Tenascin in salivary gland tumours.
    Soini Y; Pääkkö P; Virtanen I; Lehto VP
    Virchows Arch A Pathol Anat Histopathol; 1992; 421(3):217-22. PubMed ID: 1384222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tenascin-C tissue concentration in inflammatory and neoplastic diseases of the colon mucosa.
    Riedl S; Kadmon M; Tandara A; Hinz U; Möller P; Faissner A
    Anticancer Res; 1997; 17(4B):3165-6. PubMed ID: 9329627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical staining of tenascin in Warthin's tumor and in oncocytoma.
    Sunardhi-Widyaputra S; Van Damme B
    Oral Surg Oral Med Oral Pathol; 1993 Sep; 76(3):325-9. PubMed ID: 7690924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns and composition of basement membranes in colon adenomas and adenocarcinomas.
    Visser R; Arends JW; Leigh IM; Bosman FT
    J Pathol; 1993 Jul; 170(3):285-90. PubMed ID: 8133402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationships among tenascin expression, DNA ploidy patterns, and multidrug resistance gene product (P-glycoprotein) in human colon carcinoma.
    Sugawara I; Hirakoshi J; Kusakabe M; Masunaga A; Itoyama S; Sakakura T
    Jpn J Cancer Res; 1993 Jul; 84(7):703-7. PubMed ID: 7690353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical demonstration of tenascin and fibronectin in odontogenic tumours and human fetal tooth germs.
    Nagai N; Yamachika E; Nishijima K; Inoue M; Shin HI; Suh MS; Nagatsuka H
    Eur J Cancer B Oral Oncol; 1994 May; 30B(3):191-5. PubMed ID: 7522711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of tenascin in healing incision, excision and laser wounds.
    Luomanen M; Virtanen I
    J Oral Pathol Med; 1993 Jan; 22(1):41-5. PubMed ID: 7678297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical study of basement membrane reconstruction by an epidermis-dermis recombination experiment using cultured chick embryonic skin: induction of tenascin.
    Akimoto Y; Obinata A; Endo H; Hirano H
    J Histochem Cytochem; 1992 Aug; 40(8):1129-37. PubMed ID: 1377733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tenascin may not be required for intestinal villus development.
    Desloges N; Simoneau A; Jutras S; Beaulieu JF
    Int J Dev Biol; 1994 Dec; 38(4):737-9. PubMed ID: 7540034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basement membrane and extracellular interstitial matrix components in bladder neoplasia--evidence of angiogenesis.
    Deen S; Ball RY
    Histopathology; 1994 Nov; 25(5):475-81. PubMed ID: 7532615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The extracellular matrix components, tenascin and fibronectin, in Hirschsprung's disease: an immunohistochemical study.
    Parikh DH; Tam PK; Van Velzen D; Edgar D
    J Pediatr Surg; 1994 Oct; 29(10):1302-6. PubMed ID: 7528797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tenascin and other adhesion-modulating proteins in cancer.
    Chiquet-Ehrismann R
    Semin Cancer Biol; 1993 Oct; 4(5):301-10. PubMed ID: 7504958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific expression of tenascin in human colonic neoplasms.
    Sakai T; Kawakatsu H; Hirota N; Yokoyama T; Sakakura T; Saito M
    Br J Cancer; 1993 May; 67(5):1058-64. PubMed ID: 7684238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced tenascin expression in colonic carcinoma with lymphogenous metastasis.
    Sugawara I; Hirakoshi J; Masunaga A; Itoyama S; Sakakura T
    Invasion Metastasis; 1991; 11(6):325-31. PubMed ID: 1726610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical expression of tenascin in normal stomach tissue, gastric carcinomas and gastric carcinoma in lymph nodes.
    Ikeda Y; Mori M; Kajiyama K; Haraguchi Y; Sasaki O; Sugimachi K
    Br J Cancer; 1995 Jul; 72(1):189-92. PubMed ID: 7541237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of CD59, a complement regulator protein and a second ligand of the CD2 molecule, and CD46 in normal and neoplastic colorectal epithelium.
    Koretz K; Brüderlein S; Henne C; Möller P
    Br J Cancer; 1993 Nov; 68(5):926-31. PubMed ID: 7692919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tenascin distribution in the normal human breast is altered during the menstrual cycle and in carcinoma.
    Ferguson JE; Schor AM; Howell A; Ferguson MW
    Differentiation; 1990 Feb; 42(3):199-207. PubMed ID: 1692795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.